Trade CGON anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
CG Oncology, Inc. (CGON) is trading at US$74.11, down 0.75% today as of Sep 8, 13:57 EDT. The company has a market capitalisation of US$7.07B. Over the past 52 weeks, CGON has traded between US$32.08 and US$80.97. On Syfe you can trade CGON with $0 commission and add it to your watchlist.
| Previous close | US$74.67 |
|---|---|
| Market cap | US$7.07B |
| 52-week range | US$32.08 – US$80.97 |
| Volume | 282.52K |
| Exchange | US |
Add to Watchlist
Set Price Alert
CG Oncology, Inc.
CG Oncology, Inc. is a clinical biopharmaceutical company, which engages in the development and commercialization of bladder-sparing therapeutic patients afflicted with bladder cancer. It offers cretostimogene, a product initially in clinical development for the treatment of patients with Non-Muscle Invasive Bladder Cancer (NMIBC). The company was founded by Alex Yeung and Paul A. DeRidder on September 24, 2010 and is headquartered in Dallas, TX.
Year: 2024
BofA Adjusts Price Target on CG Oncology to $88 From $87
Aug 7, 12:10 PM · MT Newswires
RBC Adjusts PT on CG Oncology to $79 From $81, Maintains Outperform Speculative Risk Rating
Aug 7, 11:15 AM · MT Newswires
CG Oncology Q2 Net Loss Widens
Aug 6, 12:39 PM · MT Newswires
--Earnings Flash (CGON) CG Oncology Posts Q2 Net Loss $0.90 a Share, vs. FactSet Est of $0.66 Loss
Aug 6, 12:20 PM · MT Newswires
-- Earnings Flash (CGON) CG Oncology, Inc. Reports Q2 Revenue $1.2M
Aug 6, 12:16 PM · MT Newswires
CG Oncology, Inc. (CGON) stock is trading at US$74.11, -0.75% from the previous close of US$74.67.
The market cap for CG Oncology, Inc. (CGON) stock is approximately US$7.07B.
The 52-week high for CG Oncology, Inc. (CGON) stock is US$80.97.
The 52-week low for CG Oncology, Inc. (CGON) stock is US$32.08.
CG Oncology, Inc. (CGON) does not currently pay a dividend.
Stay on top of CGON
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
